Contribute
Subscribe
Log In
Try STAT+
Today
My Account
My Account
Billing
Log Out
Try STAT+
Today
My Account
Search
Back
Topics
Coronavirus
Health
Pharma
Biotech
Politics & Policy
Health Tech
In the Lab
Business
Artificial Intelligence
Health Disparities
Prescription Politics
Opinion
First Opinion
The Pharmalot View
Adam's Take
Matt's Take
Team
Biotech & Pharma
Adam Feuerstein
Damian Garde
Matthew Herper
Meghana Keshavan
Kate Sheridan
Ed Silverman
Health Tech
Mario Aguilar
Erin Brodwin
Katie Palmer
Casey Ross
Politics
Rachel Cohrs
Lev Facher
Nicholas Florko
Health & Science
Eric Boodman
Helen Branswell
Shraddha Chakradhar
Elizabeth Cooney
Olivia Goldhill
Andrew Joseph
Usha Lee McFarling
Jennifer Adaeze Okwerekwu
Nicholas St. Fleur
Team
View All
Events
STAT Events
Industry Events Calendar
2021 STAT Health Tech Summit
2020 STAT Summit
Webinars
Newsletters
Reports
Video
Podcasts
The Readout LOUD
First Opinion Podcast
STAT+
Exclusive analysis of biotech, pharma, and the life sciences
Learn More
The Latest
My Account
Topics
Biotech
Pharma
Policy
Health Tech
Business
Columns
Adam's Take
Matt's Take
The Pharmalot View
Tools
CRISPR Tracker
Drug Pricing Policy Tracker
Events
STAT+ Conversations
All STAT Events
Account
My Account
Billing
Subscribe
Log In
Help
More
Contribute
Group Subscriptions
Follow Us
Trending:
Coronavirus
Morning Rounds
First Opinion
Health
DOJ
All Coverage
Pharmalot
By
Ed Silverman
Feds probe drug maker for prices of generic dermatology meds
Pharmalot
By
Ed Silverman
Consumer safety agency says Indian company sold improperly packaged drugs
Pharmalot
By
Ed Silverman
Two former device maker execs go on trial for unauthorized marketing
Pharmalot
By
Ed Silverman
Novartis and the feds squabble over 80,000 ‘sham’ speaking events
Pharmalot
By
Ed Silverman
FDA settles lawsuit, rescinds warning letter
